Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors

Patrizia Vici, Laura Pizzuti, Eriseld Krasniqi, Andrea Botticelli, Gennaro Ciliberto, Maddalena Barba

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)675-679
Number of pages5
JournalImmunotherapy
Volume12
Issue number10
DOIs
Publication statusPublished - Jul 2020

Keywords

  • Covid-19
  • immunotherapy
  • metastatic triple-negative breast cancer

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this